MUMBAI Europe's drug regulator said on Wednesday an inspection of Indian generic drugmaker Ranbaxy Laboratories Ltd's(RANB.NS) Dewas plant in India is planned for June, amid concerns about its production processes after a spate of regulatory sanctions.
Ranbaxy, which owner Japan's Daiichi Sankyo Ltd (4568.T) agreed to sell it to Sun Pharmaceutical Industries Ltd (SUN.NS) for $3.2 billion on Monday, suspended production at the Dewas plant in February to examine processes.
The company's voluntary suspension at Dewas and another plant in Toansa in the northern Punjab state in February, came after a spate of sanctions against it by the U.S. Food and Drug Administration (FDA) due to poor manufacturing processes.
Ranbaxy informed authorities in the European Union that its internal investigation revealed the Dewas site failed some so-called good manufacturing practices, the European Medicines Agency (EMA) said in a statement issued to Reuters.
A Ranbaxy spokesman did not immediately respond to requests for comment on the EMA statement.
Imports from Dewas had already been banned by the FDA back in 2008 after the agency found violations of drug manufacturing standards there. The FDA has also banned shipments from the three other Ranbaxy plants in India.
(Reporting by Zeba Siddiqui; Editing by Sumeet Chatterjee and Elaine Hardcastle)
Wall St rises as hawkish Fed boosts financial stocks
Wall Street rose on Monday morning, helped by financial stocks that gained a day after Federal Reserve Chair Janet Yellen said the case for an interest rate hike had strengthened.
Dollar at 3-week high, bonds and stocks sell off on hawkish Fed
LONDON The dollar rose to a three-week high against the yen on Monday, while bond yields surged to their highest since June and stocks sold off after senior Federal Reserve officials indicated a U.S. interest rate increase was on the cards in the near term.
Gold hits near 5-week low after Fed strikes hawkish note
LONDON Gold slid to a near five-week low on Monday after comments from top Federal Reserve officials fuelled speculation that U.S. interest rates would rise sooner rather than later, weighing on the dollar.